Late-onset Alzheimer's disease

There are 134 papers on late-onset Alzheimer's disease in aging research: 77 observational studies in people, 17 in animals, 2 in cells, 31 reviews. The newest story, Oct 6, 2026: “Genetic risk scores linked to faster progression to Alzheimer’s”.

Disease

134 papers study it120 more mention it60 findings

5 new papers in 30 daysSee all 254 papers on late-onset Alzheimer's disease

At a glance

Late-onset Alzheimer’s disease is associated with senescent and cell-cycle-reengaging neurons in a human brain study; a multi-ancestry cohort links APOE and polygenic scores with higher risk. Observational studies associate high cholesterol with disease, whereas a Mendelian randomization study links genetically predicted cholesterol with lower risk.

60 findings in 35 papers from 2018 to 2026, 5 of them since June 2026

“Inverse-variance weighting associated genetically predicted insomnia with higher odds of late-onset AD (OR = 3.36, 95% CI 1.02–10.99; P = 0.045).”
Causal association and molecular mechanisms linking insomnia to late- onset Alzheimer’s disease: an integrated Mendelian randomization and transcriptomic analysisResearch Square2026doi:10.21203/rs.3.rs-11643513/v1
  • Humans77
  • Animals17
  • Cells2
  • In silico6

Interventions

1

Alcohol

no changein humans1

1 study
  1. Alcohol was not clearly linked with late-onset Alzheimer's disease in the HRS and the ELSA.

    Humansin the HRS and the ELSA

More on Alcohol

Effects

4

Memory and language

downin humans1

1 study
  1. Late-onset Alzheimer's disease is linked with worse memory and language in humans (compared with younger-onset AD).

    Humanscompared with younger-onset AD

TBCA

upin humans1

1 study
  1. Late-onset Alzheimer's disease is linked with higher TBCA in humans (bi-directional Mendelian randomization analysis).

    Humansbi-directional Mendelian randomization analysis

More on TBCA

Neural stem cell plasticity

downin human cells1

1 study
  1. Late-onset Alzheimer's disease decreases neural stem cell plasticity in human cells.

    Cellsneural stem cell

ATG7

downin human cells1

1 study
  1. Late-onset Alzheimer's disease decreases ATG7 in NSCs derived from iPSCs of patients.

    Cellsin NSCs derived from iPSCs of patientsneural stem cell

More on ATG7

Upstream

2

Gene-gene interactions

no changein humans1

1 study
  1. gene-gene interactions were not clearly linked with late-onset Alzheimer's disease in APOE*4 negative individuals.

    Humansin APOE*4 negative individualsfemales

Low plasma Klotho

no changein humans1

1 study
  1. Low plasma Klotho was not clearly linked with late-onset Alzheimer's disease in humans (comparison of vascular dementia with late-onset Alzheimer's disease).

    Humanscomparison of vascular dementia with late-onset Alzheimer's disease

More on Low plasma Klotho

Associations

48

APOE

upin humans3OR 5.2

3 studies
  1. APOE is associated with late-onset Alzheimer's disease in humans (East Asian participants; additive genetic model) (OR 5.2, 95% CI 4.4–6.0).

    HumansEast Asian participants; additive genetic modeln = 3,196

  2. APOE is associated with late-onset Alzheimer's disease in humans.

    Review

  3. APOE raises the risk of late-onset Alzheimer's disease in humans (late-onset AD).

    Reviewlate-onset AD

More on APOE

Insulin/IGF-1 signaling

upin human cells1downin reviews1

2 studies
  1. Late-onset Alzheimer's disease is associated with insulin/IGF-1 signaling in human cells (fibroblasts from LOAD patients versus old controls).

    Cellsfibroblasts from LOAD patients versus old controlsfibroblast

  2. Late-onset Alzheimer's disease is associated with insulin/IGF-1 signaling.

    Review

More on Insulin/IGF-1 signaling

Insomnia

upin humans1OR 3.36

1 study
  1. Insomnia is associated with late-onset Alzheimer's disease in humans (Genetically predicted insomnia; two-sample Mendelian randomization) (OR 3.36, 95% CI 1.02–10.99; P = 0.045).

    HumansGenetically predicted insomnia; two-sample Mendelian randomization

More on Insomnia

Hypothalamus volume

downin humans1

1 study
  1. Late-onset Alzheimer's disease is associated with hypothalamus volume in LOAD compared with EC (p < 0.010).

    Humansin LOAD compared with EC

Depression

upin silico1OR 1.0736

1 study
  1. Depression raises the risk of late-onset Alzheimer's disease in silico (OR 1.0736, 95% CI 1.0084-1.1431).

    In silico

More on Depression

Morbidity across multiple diagnostic categories

upin humans1

1 study
  1. Late-onset Alzheimer's disease is associated with morbidity across multiple diagnostic categories in humans.

    Humansfive years and one-year preceding diagnosis

Injuries

upin humans1

1 study
  1. Late-onset Alzheimer's disease is associated with injuries in humans.

    Humans10 years before diagnosis

Psychopharmaceutical use

upin humans1

1 study
  1. Late-onset Alzheimer's disease is associated with psychopharmaceutical use in humans.

    Humans10 years before diagnosis

More on Psychopharmaceutical use

Mental health and behavioral diagnoses

upin humans1

1 study
  1. Late-onset Alzheimer's disease is associated with mental health and behavioral diagnoses in humans.

    Humans10 years before diagnosis

Simpson's clonality

downin humans1

1 study
  1. Late-onset Alzheimer's disease is associated with Simpson's clonality in humans.

    Humans

More on Simpson's clonality

All 48

Trial sponsors

Funding

11 grants since 2018

National Institute on Aging$13.7MJapan Society for the Promotion of Science¥6.5MAlzheimer's Association

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Human cohorts link late-onset Alzheimer's disease with APOE-related genetic risk, and a study of human brains links it with senescent neurons. Cholesterol results differ: observational studies associate high cholesterol with the disease, while a Mendelian randomization study links genetically predicted cholesterol with lower risk.

  2. Summary written from the findings.

Latest

Dec 2025: 12Jan 2026: 8Feb 2026: 2Mar 2026: 5Apr 2026: 7May 2026: 4Jun 2026: 5Jul 2026: 6Aug 2026: 4Sep 2026: 4Oct 2026: 5Nov 2026: 264 papers in 12 months
Alzheimer's & Dementia

Genetic risk scores linked to faster progression to Alzheimer’s

In two observational cohorts, genetic scores were linked to faster progression to Alzheimer’s disease, with hazard ratios, a measure of risk over time, of 1.25 to 2.02.In two observational cohorts, genetic scores were linked to faster progression to Alzheimer’s disease, with hazard ratios, a measure of risk over time, of 1.25 to 2.02.

Genetic association study in peopleLate-onset Alzheimer's disease
Journal of Alzheimer's Disease Reports

Statins cut Alzheimer's risk but raise other dementia risks

A Mendelian randomization analysis found total cholesterol mediated 93.91% of statins' effect on overall dementia and 84.37% on dementia in Alzheimer's disease.A Mendelian randomization analysis found total cholesterol mediated 93.91% of statins' effect on overall dementia and 84.37% on dementia in Alzheimer's disease.

Mendelian randomization in peopleStatins

See all 254 papers on late-onset Alzheimer's disease